HCAT

$1.17

Post-MarketAs of Mar 17, 8:00 PM UTC

Health Catalyst, Inc.

Historical Price

Price (Line)
Synthesizing Whystock Narrative...
Loading Financials...

Peer Comparison

JNJUNHPFE

Whystock Valuation Model

Calculated using a trailing P/E relative model adjusted by sector ROE and historical growth.
Current Price$1.17
Potential Upside
5%
Whystock Fair Value$1.23
Price
UndervaluedFair ValueOvervalued

Fundamentals

SectorHealthcare
IndustryHealth Information Services

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. The company operates in two segments: Technology and Professional Services. It offers ignite data and analytics platform that ...

Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$86.10M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
1.78
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROIC
Average efficiency. Growth may require heavy reinvestment.
-58.26%
Quick Ratio
Pristine liquidity. Sufficient cash to cover all near-term obligations.
1.73

Recent News

Motley Fool
Mar 17, 2026

Health Catalyst (HCAT) Q4 2025 Earnings Transcript

Matt Hopper: Which ended 12/31/2025. My name is Matt Hopper, Senior Vice President of Finance and Head of Investor Relations. With me on the call today are Ben Albert, our Chief Executive Officer, and Jason Alger, our Chief Financial Officer.

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
GuruFocus.com
Mar 13, 2026

Health Catalyst Inc (HCAT) Q4 2025 Earnings Call Highlights: Navigating Revenue Challenges and ...

Despite a dip in quarterly revenue, Health Catalyst Inc (HCAT) reports strong EBITDA growth and outlines strategic plans to enhance market alignment and operational efficiency.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
MarketBeat
Mar 12, 2026

Health Catalyst Q4 Earnings Call Highlights

Health Catalyst (NASDAQ:HCAT) executives used the company’s fourth-quarter and full-year 2025 earnings call to outline a leadership transition, discuss the financial impact of continued restructuring and platform migrations, and preview changes to how the company will communicate performance metrics

NEUTRAL
Neutral flow. Standard news cycle with no clear sentiment tilt.
Zacks
Mar 12, 2026

Health Catalyst (HCAT) Reports Q4 Earnings: What Key Metrics Have to Say

Although the revenue and EPS for Health Catalyst (HCAT) give a sense of how its business performed in the quarter ended December 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.

BULLISH
Positive press. Headlines skewed toward growth and analyst upgrades.
Zacks
Mar 12, 2026

Health Catalyst (HCAT) Lags Q4 Earnings Estimates

Health Catalyst (HCAT) delivered earnings and revenue surprises of -14.26% and +1.45%, respectively, for the quarter ended December 2025. Do the numbers hold clues to what lies ahead for the stock?

BEARISH
Negative press. News cycle fixated on risk factors or misses.